Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rangnekar

Showing results (31-40 of 330) with videos related to

Pageof 33
Sort By:
Cancer Biology & Therapy|December 23, 2009
Targeting plasma membrane GRP78 for cancer growth inhibitionSteve Schwarze, Vivek M Rangnekar
Cancer Biology & Therapy|October 7, 2008
Apoptosis and tumor resistance conferred by Par-4Yanming Zhao, Vivek M Rangnekar
Alimentary Pharmacology & Therapeutics|May 23, 2012
Meta-analysis: IL-28B genotype and sustained viral clearance in HCV genotype 1 patientsA S Rangnekar, R J Fontana
Experimental Cell Research|February 5, 2003
Apoptosis by Par-4 in cancer and neurodegenerative diseasesNadia El-Guendy, Vivek M Rangnekar
Clinical Chemistry|July 1, 1982
gamma-Glutamyltransferase activity in human milkK P Patil, N R Rangnekar
Current Pharmaceutical Design|February 18, 2004
Molecular therapy intervention prospects in prostate cancerYashraj D Rege, Vivek M Rangnekar
Gastroenterology|October 14, 2008
Methylnaltrexone: a new treatment for an old problemAmol S Rangnekar, William D Chey
Evidence-Based Medicine|February 1, 2007
Review: tissue transglutaminase test is almost as accurate as endomysial antibody test for diagnosis of coeliac diseaseAmol S Rangnekar, William D Chey
Minerva Gastroenterologica E Dietologica|May 19, 2011
An update on drug induced liver injuryA S Rangnekar, R J Fontana
British Journal of Urology|May 1, 1993
Serum and urinary zinc levels in urolithiasisG V Rangnekar, M S Gaur
Pageof 33

Showing results (31-40 of 330) with videos related to

Sort By:
Pageof 33
Cancer Biology & Therapy|December 23, 2009
Targeting plasma membrane GRP78 for cancer growth inhibitionSteve Schwarze, Vivek M Rangnekar
Cancer Biology & Therapy|October 7, 2008
Apoptosis and tumor resistance conferred by Par-4Yanming Zhao, Vivek M Rangnekar
Alimentary Pharmacology & Therapeutics|May 23, 2012
Meta-analysis: IL-28B genotype and sustained viral clearance in HCV genotype 1 patientsA S Rangnekar, R J Fontana
Experimental Cell Research|February 5, 2003
Apoptosis by Par-4 in cancer and neurodegenerative diseasesNadia El-Guendy, Vivek M Rangnekar
Clinical Chemistry|July 1, 1982
gamma-Glutamyltransferase activity in human milkK P Patil, N R Rangnekar
Current Pharmaceutical Design|February 18, 2004
Molecular therapy intervention prospects in prostate cancerYashraj D Rege, Vivek M Rangnekar
Gastroenterology|October 14, 2008
Methylnaltrexone: a new treatment for an old problemAmol S Rangnekar, William D Chey
Evidence-Based Medicine|February 1, 2007
Review: tissue transglutaminase test is almost as accurate as endomysial antibody test for diagnosis of coeliac diseaseAmol S Rangnekar, William D Chey
Minerva Gastroenterologica E Dietologica|May 19, 2011
An update on drug induced liver injuryA S Rangnekar, R J Fontana
British Journal of Urology|May 1, 1993
Serum and urinary zinc levels in urolithiasisG V Rangnekar, M S Gaur
Pageof 33